Clinical Trials · NCT00711620

Efficacy of Thymosin alpha1 for Severe Sepsis

CompletedN/AThymosin Alpha-1 (Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
Sun Yat-sen University
Enrollment
366
Start date
May 2008
Locations
1 site, China
Primary endpoint
28-day Mortality
View Thymosin-Alpha-1 compound reference